Physician profile
Grace Smith
NPI 1578253357
$945.51
in general payments reported to CMS, 2019-2025
17 companies · $946 in 2025
The $946 reported for 2025 was more than what 79% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.52 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $156.39 | 2025 | Otezla, Repatha |
| Novo Nordisk INC | $132.91 | 2025 | Ozempic, Wegovy, Rybelsus |
| Astellas Pharma US INC | $116.83 | 2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $85.52 | 2025 | Rexulti |
| Pfizer INC. | $67.88 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $62.07 | 2025 | Caplyta |
| Abbvie INC. | $60.23 | 2025 | |
| Aimmune Therapeutics, INC. | $46.36 | 2025 | Zenpep |
| Lilly USA, LLC | $41.54 | 2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $37.62 | 2025 | |
| Seqirus USA INC | $31.55 | 2025 | Flucelvax, Fluad |
| Exact Sciences Corporation | $22.37 | 2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $21.23 | 2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.07 | 2025 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $15.88 | 2025 | Trintellix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $13.59 | 2025 | Contrave |
| Sumitomo Pharma America, INC. | $13.47 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.